NM_152743.4(BRAT1):c.2290C>G (p.Pro764Ala) AND Neonatal-onset encephalopathy with rigidity and seizures

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jun 3, 2019
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001219106.2

Allele description [Variation Report for NM_152743.4(BRAT1):c.2290C>G (p.Pro764Ala)]

NM_152743.4(BRAT1):c.2290C>G (p.Pro764Ala)

Gene:

BRAT1:BRCA1 associated ATM activator 1 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7p22.3

Genomic location:

Preferred name:

NM_152743.4(BRAT1):c.2290C>G (p.Pro764Ala)

HGVS:

NC_000007.14:g.2538245G>C
NG_032167.1:g.22514C>G
NM_001350626.2:c.2470C>G
NM_001350627.2:c.1765C>G
NM_152743.4:c.2290C>GMANE SELECT
NP_001337555.1:p.Pro824Ala
NP_001337556.1:p.Pro589Ala
NP_689956.2:p.Pro764Ala
NC_000007.13:g.2577879G>C
NM_152743.3:c.2290C>G
NR_146879.2:n.2473C>G

Protein change:

P589A

Links:

dbSNP: rs754574676

NCBI 1000 Genomes Browser:

rs754574676

Molecular consequence:

NM_001350626.2:c.2470C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001350627.2:c.1765C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_152743.4:c.2290C>G - missense variant - [Sequence Ontology: SO:0001583]
NR_146879.2:n.2473C>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Neonatal-onset encephalopathy with rigidity and seizures
Synonyms:: Rigidity and multifocal seizure syndrome, lethal neonatal; Lethal neonatal spasticity-epileptic encephalopathy syndrome
Identifiers:: MONDO: MONDO:0013784; MedGen: C3281029; Orphanet: 435845; OMIM: 614498

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001391027	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Jun 3, 2019)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001391027

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Jun 3, 2019)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001391027.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This sequence change replaces proline with alanine at codon 764 of the BRAT1 protein (p.Pro764Ala). The proline residue is weakly conserved and there is a small physicochemical difference between proline and alanine. This variant is present in population databases (rs754574676, ExAC 0.006%). This variant has not been reported in the literature in individuals with BRAT1-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine